0001851182 false --12-31 0001851182 2022-12-09 2022-12-09 0001851182 fhlt:UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember 2022-12-09 2022-12-09 0001851182 us-gaap:CommonStockMember 2022-12-09 2022-12-09 0001851182 fhlt:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2022-12-09 2022-12-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 15, 2022 (December 9, 2022)

 

Future Health ESG Corp.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40788   86-2305680
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 

8 The Green, Suite 12081

Dover, DE 19901

(Address of principal executive offices, including zip code)

 

(Registrant’s telephone number, including area code): (833) 388-8734

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading Symbol(s)

  

Name of each exchange on which registered

Units, each consisting of one share of common stock and one-half of one redeemable Warrant   FHLTU   The Nasdaq Stock Market LLC
Common stock, par value $0.0001 per share   FHLT   The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share   FHLTW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 5.03.Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On December 9, 2022, Future Health ESG Corp., a Delaware corporation (the “Company”), held a special meeting of stockholders (the “Meeting”). At the Meeting, the Company’s stockholders approved an amendment (the “Charter Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to extend the date by which the Company must consummate its initial business combination (the “Initial Business Combination”) from December 14, 2022 to December 31, 2023. On December 9, 2022, the Company filed a copy of the Charter Amendment with the Secretary of State of the State of Delaware. A copy of the Charter Amendment is attached as Exhibit 3.1 hereto and is incorporated herein by reference.

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

 

At the Meeting, the Company’s stockholders approved the Charter Amendment extending the date by which the Company must consummate the Initial Business Combination from December 14, 2022 to December 31, 2023 (the “Extension Amendment Proposal”).

 

The final voting results for the Extension Amendment Proposal were as follows:

 

For   Against   Abstain
19,732,100   3,058   0

 

In connection with the Meeting, stockholders holding 18,408,463 shares of the Company’s common stock (the “public shares”) exercised their right to redeem their shares for a pro rata portion of the funds in the Company’s trust account (the “Trust Account”). As a result, approximately $187 million (approximately $10.14 per public share) will be removed from the Trust Account to pay such holders and approximately $16 million will remain in the Trust Account. Following redemptions, the Company will have 6,591,537 public shares outstanding.

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits. The following exhibits are filed with this Form 8-K:

 

Exhibit No.   Description of Exhibits
3.1   Amendment to the Amended and Restated Certificate of Incorporation, filed on December 9, 2022.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 15, 2022 

  FUTURE HEALTH ESG CORP.
     
  By: /s/ Bradley A. Bostic
  Name:   Bradley A. Bostic
  Title:  Chief Executive Officer

 

 

 

Future Health ESG (NASDAQ:FHLT)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Future Health ESG Charts.
Future Health ESG (NASDAQ:FHLT)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Future Health ESG Charts.